Trump Administration Says It's Not Canceling Tuskegee-Style Medical Study That Will Withhold Hepatitis Vaccine From Newborns
Futurism • • general
Key Points:
- Robert F. Kennedy Jr.’s Department of Health and Human Services (HHS) planned a $1.6 million randomized controlled trial in Guinea-Bissau to study the effects of withholding hepatitis B vaccines from 7,000 newborns to compare their health outcomes with vaccinated infants.
- The study, intended to begin in 2027, has sparked outrage among health officials and researchers due to ethical concerns, with Guinea-Bissau officials and Africa CDC reportedly halting the trial, though HHS denies its cancellation and insists it will proceed as planned.
- Experts have condemned the trial as reminiscent of the unethical Tuskegee syphilis study, highlighting the moral issue of deliberately exposing infants to a preventable disease to observe potential long-term effects
 { path { fill: %23EEEFE9 } })